# West Pharmaceutical (WST) — News

WST · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/wst/news

## Recent headlines

- [West Pharmaceutical Services, Inc.: Barclays raises target price to $440 from $400](https://www.ainvest.com/news/west-pharmaceutical-services-barclays-raises-target-price-440-400-2610) — AInvest Wire, Oct 7, 2026
  Barclays has raised its price target for West Pharmaceutical Services, Inc. (WST) to $440 from $400, while maintaining its "Overweight" rating for the stock . This adjustment reflects growing confidence in the company’s performance and prospects. The stock closed at $372.64 on October 6, 2026, with…
- [ESG stocks rose in regular trading, with West Pharmaceutical Services up 2.5%, Trimble gaining 2.3% and Edwards Lifesciences rising 2.3%.](https://www.ainvest.com/news/esg-stocks-rose-regular-trading-west-pharmaceutical-services-2-5-trimble-gaining-2-3-edwards-lifesciences-rising-2-3-2610) — AInvest Wire, Oct 5, 2026
  On October 5, 2026, ESG-focused stocks saw gains in regular trading, reflecting continued investor interest in sustainability-oriented equities. West Pharmaceutical Services (WPH) rose 2.5%, Trimble (TRMB) advanced 2.3%, and Edwards Lifesciences (EW) climbed 2.3%. These movements align with broader…
- [West Pharmaceutical Services Inc.: Morgan Stanley raises to overweight from equal-weight](https://www.ainvest.com/news/west-pharmaceutical-services-morgan-stanley-raises-overweight-equal-weight-2609) — AInvest Wire, Sep 22, 2026
- [West Pharmaceutical Services Inc.: Morgan Stanley raises target price to $400.00 from $365.00](https://www.ainvest.com/news/west-pharmaceutical-services-morgan-stanley-raises-target-price-400-00-365-00-2609) — AInvest Wire, Sep 22, 2026
- [Waystar shares up 4% after Reuters reports co explores options including sale](https://www.ainvest.com/news/waystar-shares-4-reuters-reports-explores-options-including-sale-2609) — AInvest Wire, Sep 15, 2026
  Waystar Inc. (WST) shares rose approximately 4% in early trading on September 15, 2026, following a report by Reuters that the company is exploring strategic options, including a potential sale . The report indicated that the company has engaged financial advisors to evaluate various possibilities,…

## Similar Stocks

- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock
- [CHE](https://www.lighthorse.io/tickers/che) — Chemed Corp

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).